Mitochondrial dysfunction and seizures: The neuronal energy crisis

The Lancet Neurology

Volumn 14, Issue 9, 2015, Pages 956-966

  Zsurka, Gábor ^a   Kunz, Wolfram S ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MITOCHONDRIAL DNA; UBIDECARENONE;

ACTION POTENTIAL; ALPERS DISEASE; AMINO ACID METABOLISM; BIOENERGY; CENTRAL NERVOUS SYSTEM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY CONSUMPTION; FATTY ACID OXIDATION; GENE MUTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTRACTABLE EPILEPSY; LEIGH DISEASE; MERRF SYNDROME; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL DNA REPLICATION; MITOCHONDRIAL ENCEPHALOPATHY; MITOCHONDRION; MUSCLE HYPOTONIA; NEPHROTIC SYNDROME; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN QUALITY; PROTEIN SYNTHESIS; PSYCHOMOTOR RETARDATION; REVIEW; SEIZURE; SYNAPTIC TRANSMISSION; ANIMAL; BRAIN; ENERGY METABOLISM; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEIZURES;

ANIMALS; BRAIN; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; SEIZURES;

EID: 84939528282     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00148-9     Document Type: Review

References (125)

1. Davis RE, Williams M Mitochondrial function and dysfunction: an update. J Pharmacol Exp Ther 2012, 342:598-607.
2. Duchen MR Mitochondria and calcium: from cell signalling to cell death. J Physiol 2000, 529:57-68.
3. Wallace DC, Fan W, Procaccio V Mitochondrial energetics and therapeutics. Annu Rev Pathol 2010, 5:297-348.
4. Kovács R, Schuchmann S, Gabriel S, Kann O, Kardos J, Heinemann U Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. J Neurophysiol 2002, 88:2909-2918.
5. Hardie DG, Ross FA, Hawley SA AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012, 13:251-262.
6. Attwell D, Laughlin SB An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 2001, 21:1133-1145.
7. Harris JJ, Jolivet R, Attwell D Synaptic energy use and supply. Neuron 2012, 75:762-777.
8. Liotta A, Rösner J, Huchzermeyer C, et al. Energy demand of synaptic transmission at the hippocampal Schaffer-collateral synapse. J Cereb Blood Flow Metab 2012, 32:2076-2083.
9. Sajic M, Mastrolia V, Lee CY, et al. Impulse conduction increases mitochondrial transport in adult mammalian peripheral nerves in vivo. PLoS Biol 2013, 11:e1001754.
10. Rangaraju V, Calloway N, Ryan TA Activity-driven local ATP synthesis is required for synaptic function. Cell 2014, 156:825-835.
11. Verstreken P, Ly CV, Venken KJ, Koh TW, Zhou Y, Bellen HJ Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005, 47:365-378.
12. Safiulina D, Kaasik A Energetic and dynamic: how mitochondria meet neuronal energy demands. PLoS Biol 2013, 11:e1001755.
13. Pathak D, Sepp KJ, Hollenbeck PJ Evidence that myosin activity opposes microtubule-based axonal transport of mitochondria. J Neurosci 2010, 30:8984-8992.
14. Brickley K, Stephenson FA Trafficking kinesin protein (TRAK)-mediated transport of mitochondria in axons of hippocampal neurons. J Biol Chem 2011, 286:18079-18092.
15. 2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell 2009, 136:163-174.
16. Perkins GA, Tjong J, Brown JM, et al. The micro-architecture of mitochondria at active zones: electron tomography reveals novel anchoring scaffolds and cristae structured for high-rate metabolism. J Neurosci 2010, 30:1015-1026.
17. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990, 61:931-937.
18. Phe mutation causes MERRF syndrome. Neurology 2004, 62:2119-2121.
19. Zsurka G, Hampel KG, Nelson I, et al. Severe epilepsy as the major symptom of new mutations in the mitochondrial tRNA(Phe) gene. Neurology 2010, 74:507-512.
20. Human DNA Polymerase Gamma Mutation Database (POLG) (accessed May 15, 2015). http://tools.niehs.nih.gov/polg/_assets/documents/POLG-mutation-large.pdf.
21. Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, Lönnqvist T Recessive twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007, 130:3032-3040.
22. A Human Mitochondrial Genome Database MITOMAP, (accessed May 15, 2015). http://www.mitomap.org/bin/view.pl/MITOMAP/MutationsRNA.
23. Hallmann K, Zsurka G, Moskau-Hartmann S, et al. A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy. Neurology 2014, 83:2183-2187.
24. Elo JM, Yadavalli SS, Euro L, et al. Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet 2012, 21:4521-4529.
25. Edvardson S, Shaag A, Kolesnikova O, et al. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 2007, 81:857-862.
26. Poduri A, Heinzen EL, Chitsazzadeh V, et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol 2013, 74:873-882.
27. Molinari F, Raas-Rothschild A, Rio M, et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet 2005, 76:334-339.
28. Mollet J, Delahodde A, Serre V, et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 2008, 82:623-630.
29. 10 deficiency. Am J Hum Genet 2006, 78:345-349.
30. Lim SC, Smith KR, Stroud DA, et al. A founder mutation in PET100 causes isolated complex IV deficiency in Lebanese individuals with Leigh syndrome. Am J Hum Genet 2014, 94:209-222.
31. Garcia-Diaz B, Barros MH, Sanna-Cherchi S, et al. Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. Am J Hum Genet 2012, 91:729-736.
32. Besse A, Wu P, Bruni F, et al. The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism. Cell Metab 2015, 21:417-427.
33. Hirano M, Kunz WS, DiMauro S Mitochondrial diseases. Epilepsy: a comprehensive textbook 2008, vol 3:2621-2630. Lippincott Williams & Wilkins, Philadelphia, PA, USA. 2nd edn. J. Engel, T.A. Pedley (Eds.).
34. Enriquez JA, Chomyn A, Attardi G mtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat Genet 1995, 10:47-55.
35. Vielhaber S, Varlamov DA, Kudina TA, et al. Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients harboring the A3243G point mutation or large-scale deletions of mitochondrial DNA. J Neuropathol Exp Neurol 2002, 61:885-895.
36. Bindoff LA, Engelsen BA Mitochondrial diseases and epilepsy. Epilepsia 2012, 53(suppl 4):92-97.
37. Neeve VC, Samuels DC, Bindoff LA, et al. What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?. Brain 2012, 135:3614-3626.
38. Ruhoy IS, Saneto RP The genetics of Leigh syndrome and its implications for clinical practice and risk management. Appl Clin Genet 2014, 7:221-234.
39. Koene S, Rodenburg RJ, van der Knaap MS, et al. Natural disease course and genotype-phenotype correlations in complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis 2012, 35:737-747.
40. Calvo SE, Tucker EJ, Compton AG, et al. High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat Genet 2010, 42:851-858.
41. Barghuti F, Elian K, Gomori JM, et al. The unique neuroradiology of complex I deficiency due to NDUFA12L defect. Mol Genet Metab 2008, 94:78-82.
42. Saada A, Vogel RO, Hoefs SJ, et al. Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am J Hum Genet 2009, 84:718-727.
43. Pagliarini DJ, Calvo SE, Chang B, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
44. Ghezzi D, Sevrioukova I, Invernizzi F, et al. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am J Hum Genet 2010, 86:639-649.
45. Wedatilake Y, Brown RM, McFarland R, et al. SURF1 deficiency: a multi-centre natural history study. Orphanet J Rare Dis 2013, 8:96.
46. Antonicka H, Mattman A, Carlson CG, et al. Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 2003, 72:101-114.
47. Verdijk RM, de Krijger R, Schoonderwoerd K, et al. Phenotypic consequences of a novel SCO2 gene mutation. Am J Med Genet A 2008, 146A:2822-2827.
48. Ghezzi D, Saada A, D'Adamo P, et al. FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency. Am J Hum Genet 2008, 83:415-423.
49. Pitceathly RD, Rahman S, Wedatilake Y, et al. NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease. Cell Rep 2013, 3:1795-1805. the UK10K Consortium.
50. Jonckheere AI, Renkema GH, Bras M, et al. A complex V ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy. Brain 2013, 136:1544-1554.
51. Grafakou O, Oexle K, van den Heuvel L, et al. Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation. Eur J Pediatr 2003, 162:714-718.
52. Coughlin EM, Christensen E, Kunz PL, et al. Molecular analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab 1998, 63:254-262.
53. Spiegel R, Pines O, Ta-Shma A, et al. Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2. Am J Hum Genet 2012, 90:518-523.
54. Diodato D, Melchionda L, Haack TB, et al. VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. Hum Mutat 2014, 35:983-989.
55. Vanlander AV, Menten B, Smet J, et al. Two siblings with homozygous pathogenic splice-site variant in mitochondrial asparaginyl-tRNA synthetase (NARS2). Hum Mutat 2015, 36:222-231.
56. Boczonadi V, Horvath R Mitochondria: impaired mitochondrial translation in human disease. Int J Biochem Cell Biol 2014, 48:77-84.
57. Copeland WC, Longley MJ Mitochondrial genome maintenance in health and disease. DNA Repair (Amst) 2014, 19:190-198.
58. Tzoulis C, Tran GT, Coxhead J, et al. Molecular pathogenesis of polymerase γ-related neurodegeneration. Ann Neurol 2014, 76:66-81.
59. Bourdon A, Minai L, Serre V, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007, 39:776-780.
60. Giordano C, Sebastiani M, Plazzi G, et al. Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. Gastroenterology 2006, 130:893-901.
61. Götz A, Isohanni P, Pihko H, et al. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain 2008, 131:2841-2850.
62. Salviati L, Sacconi S, Mancuso M, et al. Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 2002, 52:311-317.
63. Elpeleg O, Miller C, Hershkovitz E, et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 2005, 76:1081-1086.
64. Bastin J Regulation of mitochondrial fatty acid β-oxidation in human: what can we learn from inborn fatty acid β-oxidation deficiencies?. Biochimie 2014, 96:113-120.
65. Nakano K, Kobayashi K, Okano Y, Aso K, Ohtsuka Y Intractable absence seizures in hyperinsulinism-hyperammonemia syndrome. Pediatr Neurol 2012, 47:119-122.
66. Molinari F, Kaminska A, Fiermonte G, et al. Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts. Clin Genet 2009, 76:188-194.
67. Wibom R, Lasorsa FM, Töhönen V, et al. AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 2009, 361:489-495.
68. Yazaki M, Takei Y, Kobayashi K, Saheki T, Ikeda S Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). Intern Med 2005, 44:188-195.
69. Rugarli EI, Langer T Mitochondrial quality control: a matter of life and death for neurons. EMBO J 2012, 31:1336-1349.
70. Wortmann SB, Ziętkiewicz S, Kousi M, et al. CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet 2015, 96:245-257.
71. Saunders C, Smith L, Wibrand F, et al. CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduria. Am J Hum Genet 2015, 96:258-265.
72. + Lon protease. Am J Hum Genet 2015, 96:121-135.
73. Folbergrová J, Kunz WS Mitochondrial dysfunction in epilepsy. Mitochondrion 2012, 12:35-40.
74. Kunz WS, Kudin AP, Vielhaber S, et al. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 2000, 48:766-773.
75. Otáhal J, Folbergrová J, Kovacs R, Kunz WS, Maggio N Epileptic focus and alteration of metabolism. Int Rev Neurobiol 2014, 114:209-243.
76. Baron M, Kudin AP, Kunz WS Mitochondrial dysfunction in neurodegenerative disorders. Biochem Soc Trans 2007, 35:1228-1231.
77. Kann O, Kovács R Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007, 292:C641-C657.
78. Kann O, Huchzermeyer C, Kovács R, Wirtz S, Schuelke M Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. Brain 2011, 134:345-358.
79. Malinska D, Kulawiak B, Kudin AP, et al. Complex III-dependent superoxide production of brain mitochondria contributes to seizure-related ROS formation. Biochim Biophys Acta 2010, 1797:1163-1170.
80. Brennan AM, Suh SW, Won SJ, et al. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 2009, 12:857-863.
81. Kovac S, Domijan AM, Walker MC, Abramov AY Seizure activity results in calcium- and mitochondria-independent ROS production via NADPH and xanthine oxidase activation. Cell Death Dis 2014, 5:e1442.
82. Claude J, Linnartz-Gerlach B, Kudin AP, Kunz WS, Neumann H Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst. J Neurosci 2013, 33:18270-18276.
83. Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 2004, 45:1478-1487.
84. Yamamoto H, Tang HW Preventive effect of melatonin against cyanide-induced seizures and lipid peroxidation in mice. Neurosci Lett 1996, 207:89-92.
85. Urbanska EM, Blaszczak P, Saran T, Kleinrok Z, Turski WA Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur J Pharmacol 1998, 359:55-58.
86. Sanganahalli BG, Herman P, Hyder F, Kannurpatti SS Mitochondrial calcium uptake capacity modulates neocortical excitability. J Cereb Blood Flow Metab 2013, 33:1115-1126.
87. Trotti D, Danbolt NC, Volterra A Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?. Trends Pharmacol Sci 1998, 19:328-334.
88. Kudin AP, Zsurka G, Elger CE, Kunz WS Mitochondrial involvement in temporal lobe epilepsy. Exp Neurol 2009, 218:326-332.
89. Tang Y, Zucker RS Mitochondrial involvement in post-tetanic potentiation of synaptic transmission. Neuron 1997, 18:483-491.
90. Bindokas VP, Lee CC, Colmers WF, Miller RJ Changes in mitochondrial function resulting from synaptic activity in the rat hippocampal slice. J Neurosci 1998, 18:4570-4587.
91. Pan X, Liu J, Nguyen T, et al. The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol 2013, 15:1464-1472.
92. Logan CV, Szabadkai G, Sharpe JA, et al. Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat Genet 2014, 46:188-193. the UK10K Consortium.
93. Sesti F, Liu S, Cai SQ Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration?. Trends Cell Biol 2010, 20:45-51.
94. Koopman WJ, Verkaart S, van Emst-de Vries SE, et al. Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment. Biochim Biophys Acta 2008, 1777:853-859.
95. + transport in canine brain. Stroke 1981, 12:726-730.
96. Ames A CNS energy metabolism as related to function. Brain Res Brain Res Rev 2000, 34:42-68.
97. Kann O, Kovács R, Njunting M, et al. Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans. Brain 2005, 128:2396-2407.
98. Althaus AL, Sagher O, Parent JM, Murphy GG Intrinsic neurophysiological properties of hilar ectopic and normotopic dentate granule cells in human temporal lobe epilepsy and a rat model. J Neurophysiol 2015, 113:1184-1194.
99. Gulyás AI, Buzsáki G, Freund TF, Hirase H Populations of hippocampal inhibitory neurons express different levels of cytochrome c. Eur J Neurosci 2006, 23:2581-2594.
100. Tokunaga M, Mita S, Sakuta R, Nonaka I, Araki S Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol 1993, 33:275-280.
101. Li X, Breteler MM, de Bruyne MC, Meinardi H, Hauser WA, Hofman A Vascular determinants of epilepsy: the Rotterdam Study. Epilepsia 1997, 38:1216-1220.
102. Hall CN, Reynell C, Gesslein B, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 2014, 508:55-60.
103. Olsen RK, Olpin SE, Andresen BS, et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 2007, 130:2045-2054.
104. Gerards M, van den Bosch BJ, Danhauser K, et al. Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. Brain 2011, 134:210-219.
105. Mayr JA, Freisinger P, Schlachter K, et al. Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 2011, 89:806-812.
106. Remes AM, Liimatta EV, Winqvist S, et al. Ubiquinone and nicotinamide treatment of patients with the 3243A→G mtDNA mutation. Neurology 2002, 59:1275-1277.
107. Yoneda M, Ikawa M, Arakawa K, et al. In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients. Biochim Biophys Acta 2012, 1820:615-618.
108. Stacpoole PW, Kerr DS, Barnes C, et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 2006, 117:1519-1531.
109. Ferriero R, Manco G, Lamantea E, et al. Phenylbutyrate therapy for pyruvate dehydrogenase complex deficiency and lactic acidosis. Sci Transl Med 2013, 5:175ra31.
110. Scarpelli M, Todeschini A, Rinaldi F, Rota S, Padovani A, Filosto M Strategies for treating mitochondrial disorders: an update. Mol Genet Metab 2014, 113:253-260.
111. Smith RAJ, Hartley RC, Cochemé HM, Murphy MP Mitochondrial pharmacology. Trends Pharmacol Sci 2012, 33:341-352.
112. Rowley S, Patel M Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic Biol Med 2013, 62:121-131.
113. Wenz T, Diaz F, Spiegelman BM, Moraes CT Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 2008, 8:249-256.
114. Viscomi C, Bottani E, Civiletto G, et al. In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis. Cell Metab 2011, 14:80-90.
115. +-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab 2014, 19:1042-1049.
116. Barros DO, Xavier SM, Barbosa CO, et al. Effects of the vitamin E in catalase activities in hippocampus after status epilepticus induced by pilocarpine in Wistar rats. Neurosci Lett 2007, 416:227-230.
117. Ogunmekan AO, Hwang PA A randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children. Epilepsia 1989, 30:84-89.
118. Xu K, Stringer JL Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizures. Epilepsy Behav 2008, 13:77-82.
119. Klein P, Tyrlikova I, Mathews GC Dietary treatment in adults with refractory epilepsy: a review. Neurology 2014, 83:1978-1985.
120. Kovac S, Abramov AY, Walker MC Energy depletion in seizures: anaplerosis as a strategy for future therapies. Neuropharmacology 2013, 69:96-104.
121. Bacman SR, Williams SL, Pinto M, Peralta S, Moraes CT Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med 2013, 19:1111-1113.
122. Gammage PA, Rorbach J, Vincent AI, Rebar EJ, Minczuk M Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations. EMBO Mol Med 2014, 6:458-466.
123. Foo JN, Liu JJ, Tan EK Whole-genome and whole-exome sequencing in neurological diseases. Nat Rev Neurol 2012, 8:508-517.
124. Herrmann PC, Herrmann EC Mitochondrial proteome: toward the detection and profiling of disease associated alterations. Methods Mol Biol 2012, 823:265-277.
125. Noebels J Pathway-driven discovery of epilepsy genes. Nat Neurosci 2015, 18:344-350.